eMedicine Specialties > Infectious Diseases > Bacterial Infections

Peptostreptococcus Infection: Follow-up

Author: Itzhak Brook, MD, MSc, Professor, Department of Pediatrics, Georgetown University School of Medicine
Contributor Information and Disclosures

Updated: Jun 17, 2008

Follow-up

Deterrence/Prevention

  • When peptostreptococci and other anaerobes predominate, aggressive treatment of acute infection can prevent chronic infection. When the risk of anaerobic infection is high, as with intra-abdominal and postsurgical infections, proper antimicrobial prophylaxis may reduce the risk.
  • Preventing oral florae aspiration by improving neurological status, suctioning oral secretions, improving oral hygiene, and maintaining lower stomach pH can reduce the risk of aspiration pneumonia and its complications.
  • Irrigating wounds, debriding necrotic tissue, draining pus, and improving the blood supply helps prevent skin and soft tissue infections.

Patient Education

Miscellaneous

Medicolegal Pitfalls

  • Failure to diagnose Peptostreptococcus infection
  • Failure to use proper antimicrobial therapy
 


More on Peptostreptococcus Infection

Overview: Peptostreptococcus Infection
Differential Diagnoses & Workup: Peptostreptococcus Infection
Treatment & Medication: Peptostreptococcus Infection
Follow-up: Peptostreptococcus Infection
References
[ CLOSE WINDOW ]

References

  1. Brook I. Anaerobic Infections. In: Diagnosis and Management. 4th Edition. New York: Informa Healthcare USA inc; 2007.

  2. Finegold SM. Anaerobic Bacteria in Human Disease. Orlando, Fla: Academic Press; 1977.

  3. Bourgault AM, Rosenblatt JE, Fitzgerald RH. Peptococcus magnus: a significant human pathogen. Ann Intern Med. Aug 1980;93(2):244-8. [Medline].

  4. Bartlett JG. Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis. Jun 1993;16 Suppl 4:S248-55. [Medline].

  5. Brook I. Recovery of anaerobic bacteria from clinical specimens in 12 years at two military hospitals. J Clin Microbiol. Jun 1988;26(6):1181-8. [Medline].

  6. Martin WJ. Isolation and identification of anaerobic bacteria in the clinical laboratory. A 2-year experience. Mayo Clin Proc. May 1974;49(5):300-8. [Medline].

  7. Brook I. Peptostreptococcal infection in children. Scand J Infect Dis. 1994;26(5):503-10. [Medline].

  8. Murdoch DA. Gram-positive anaerobic cocci. Clin Microbiol Rev. Jan 1998;11(1):81-120. [Medline].

  9. Jousime-Somers H, Summanen P, Citron DM, et al. Wadsworth-KTL Anaerobic Bacteriology Manual. 6th ed. Belmont, Calif: Star Publishing; 2002.

  10. Araki H, Kuriyama T, Nakagawa K, Karasawa T. The microbial synergy of Peptostreptococcus micros and Prevotella intermedia in a murine abscess model. Oral Microbiol Immunol. Jun 2004;19(3):177-81. [Medline].

  11. Brook I, Walker RI. Pathogenicity of anaerobic gram-positive cocci. Infect Immun. Aug 1984;45(2):320-4. [Medline].

  12. Brook I. Anaerobic bacterial bacteremia: 12-year experience in two military hospitals. J Infect Dis. Dec 1989;160(6):1071-5. [Medline].

  13. Saini S, Gupta N, Aparna, Seema, Sachdeva OP. Bacteriological study of paediatric and adult chronic suppurative otitis media. Indian J Pathol Microbiol. Jul 2005;48(3):413-6. [Medline].

  14. Brook I. Microbiology of acute and chronic maxillary sinusitis associated with an odontogenic origin. Laryngoscope. May 2005;115(5):823-5. [Medline].

  15. Blairon L, De Gheldre Y, Delaere B, Sonet A, Bosly A, Glupczynski Y. A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. Clin Microbiol Infect. Jun 2006;12(6):527-32. [Medline].

  16. Song Y, Liu C, McTeague M, Vu A, Liu JY, Finegold SM. Rapid identification of Gram-positive anaerobic coccal species originally classified in the genus Peptostreptococcus by multiplex PCR assays using genus- and species-specific primers. Microbiology. Jul 2003;149:1719-27. [Medline].

  17. Aldridge KE, Ashcraft D, Cambre K, Pierson CL, Jenkins SG, Rosenblatt JE. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob Agents Chemother. Apr 2001;45(4):1238-43. [Medline].

  18. Wexler HM, Finegold SM. Current susceptibility patterns of anaerobic bacteria. Yonsei Med J. Dec 1998;39(6):495-501. [Medline].

  19. Brook I. Treatment of anaerobic infection. Expert Rev Anti Infect Ther. Dec 2007;5(6):991-1006. [Medline].

  20. Malik NN, Goh D, McLean C, Huchzermeyer P. Orbital cellulitis caused by Peptostreptococcus. Eye. Jun 2004;18(6):643-4. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

Peptostreptococcus infection, anaerobic cocci, anaerobic gram-positive cocci, peptococci, peptostreptococci, Peptococcus, microaerophilic streptococci, Peptostreptococcus magnus, P magnus, Peptostreptococcus asaccharolyticus, P asaccharolyticus, Peptostreptococcus anaerobius, P anaerobius, Peptostreptococcus prevotii, P prevotii, Peptostreptococcus micros, P micros, Streptococcus anginosus, S anginosus, Streptococcus milleri, S milleri, Streptococcus constellatus, S constellatus, Streptococcus intermedius, S intermedius, Streptococcus morbillorum, S morbillorum, Peptostreptococcus hydrogenalis, P hydrogenalis, Staphylococcus aureus, S aureus, Streptococcus, Veillonella, Fusobacterium, Porphyromonas, Prevotella, Prevotella bivia, P bivia, Prevotella disiens, P disiens, Escherichia coli, E coli, Bacteroides fragilis, B fragilis

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Itzhak Brook, MD, MSc, Professor, Department of Pediatrics, Georgetown University School of Medicine
Itzhak Brook, MD, MSc is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, Armed Forces Infectious Diseases Society, Association of Military Surgeons of the US, Infectious Diseases Society of America, International Immunocompromised Host Society, International Society for Infectious Diseases, Medical Society of the District of Columbia, New York Academy of Sciences, Pediatric Infectious Diseases Society, Society for Ear, Nose and Throat Advances in Children, Society for Experimental Biology and Medicine, Society for Pediatric Research, Southern Medical Association, and Surgical Infection Society
Disclosure: Nothing to disclose.

Medical Editor

Douglas A Drevets, MD, Assistant Professor, Department of Medicine, Section of Infectious Disease, Oklahoma University Health Sciences Center
Douglas A Drevets, MD is a member of the following medical societies: American Association of Immunologists, American Society for Microbiology, Central Society for Clinical Research, and Christian Medical & Dental Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Aaron Glatt, MD, Professor of Clinical Medicine, New York Medical College; President and CEO, Former Chief Medical Officer, Departments of Medicine and Infectious Diseases, New Island Hospital
Aaron Glatt, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physician Executives, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Medical Association, American Society for Microbiology, American Thoracic Society, American Venereal Disease Association, Infectious Diseases Society of America, International AIDS Society, and Society for Healthcare Epidemiology of America
Disclosure: Nothing to disclose.

CME Editor

Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital
Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital
Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.